Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

PHASE3TerminatedINTERVENTIONAL
Enrollment

654

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

October 31, 2008

Conditions
Asthma, Bronchial
Interventions
DRUG

Symbicort (budesonide/formoterol) Turbuhaler

DRUG

Conventional treatment

Trial Locations (52)

Unknown

Research Site, A Coruña

Research Site, Alagón

Research Site, Alicante

Research Site, Almoradí

Research Site, Barcelona

Research Site, Burgos

Research Site, Cadiz

Research Site, Caravaca

Research Site, Cartagena

Research Site, Coslada

Research Site, Córdoba

Research Site, Donostia / San Sebastian

Research Site, Dos Hermanas

Research Site, Elche

Research Site, Fuencarral

Research Site, Fuenlabrada

Research Site, Galdakao

Research Site, Gallur

Research Site, Gandia

Research Site, Getafe

Research Site, Gijón

Research Site, Granada

Research Site, Huelva

Research Site, Huesca

Research Site, Idiazabal

Research Site, Jaén

Research Site, Lugo

Research Site, Madrid

Research Site, Mataró

Research Site, Málaga

Research Site, Oviedo

Research Site, Pamplona

Research Site, Pinto

Research Site, Pozuelo de Alarcón

Research Site, Sagunto

Research Site, Salamanca

Research Site, San Juan

Research Site, Santander

Research Site, Santiago

Research Site, Santiago de Compostela

Research Site, Seville

Research Site, Terrassa

Research Site, Valdemoro

Research Site, Valencia

Research Site, Valladolid

Research Site, Vigo

Research Site, Viladecans

Research Site, Vilanova

Research Site, Villabona

Research Site, Villanueva de la Cañada

Research Site, Vitoria-Gasteiz

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY